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Overshadowed by the amygdala: the bed nucleus of the stria
terminalis emerges as key to psychiatric disorders
MA Lebow1,2 and A Chen1,2
The bed nucleus of the stria terminalis (BNST) is a center of integration for limbic information and valence monitoring. The BNST,
sometimes referred to as the extended amygdala, is located in the basal forebrain and is a sexually dimorphic structure made up of
between 12 and 18 sub-nuclei. These sub-nuclei are rich with distinct neuronal subpopulations of receptors, neurotransmitters,
transporters and proteins. The BNST is important in a range of behaviors such as: the stress response, extended duration fear states
and social behavior, all crucial determinants of dysfunction in human psychiatric diseases. Most research on stress and psychiatric
diseases has focused on the amygdala, which regulates immediate responses to fear. However, the BNST, and not the amygdala, is
the center of the psychogenic circuit from the hippocampus to the paraventricular nucleus. This circuit is important in the
stimulation of the hypothalamic–pituitary–adrenal axis. Thus, the BNST has been largely overlooked with respect to its possible
dysregulation in mood and anxiety disorders, social dysfunction and psychological trauma, all of which have clear gender
disparities. In this review, we will look in-depth at the anatomy and projections of the BNST, and provide an overview of the current
literature on the relevance of BNST dysregulation in psychiatric diseases.
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INTRODUCTION
The bed nucleus of the stria terminalis (BNST), also referred to as the
BST,1 is fast becoming a relevant region of interest with regard to
human stress-related psychiatric disease. This is due to its
established role in sustained fear states,2 and social attachment
behaviors,3 which comprise aggressive behaviors,4,5 initiation of
mating3 and offspring and parental bonding3,6 but additionally due
to its diverse anatomy, connectivity and receptor subpopulations.
Human stress-related psychiatric diseases such as anxiety, post-
traumatic stress disorder (PTSD) and social dysfunctions all display
long-term changes in mood,7 arousal,8 sleep,7,8 appetite9 and
interest in social interactions.7–10 The BNST processes information
and readiness for response to a threat, by maintaining online
information from a vast connectivity network. Mood state and
arousal are processed via connections to the amygdala,2,11 dorsal
raphe,12 ventral tegmental area (VTA)13,14 and medial prefrontal
cortex (mPFC).15 The BNST’s projections to the hypothalamus allow
monitoring of feeding, drinking and fluid maintenance via
brainstem connections.16 Connections to the lateral septum17 and
medial amygdala (MeA)11,17 allow coordination of reproductive
behaviors as part of the social behavioral network. Since
anatomically, the BNST is sexually dimorphic,18 it may explain the
gender disparity in the prevalence and treatment of stress-related
psychiatric diseases19,20 and as such should be investigated as a
possible target for treatments. Indeed, drug targets already involve
subpopulations of receptors abundant in the BNST such as
serotonin.21–23 While research into the BNST’s role in sustained
fear is well-established2 and critical in the treatment of human
anxiety, the BNST has further promise in understanding other
human-related psychiatric diseases. This is the first review to
incorporate several roles of this region in both rodent and human
data to promote a united view of the BNST. This is essential in the
study of psychiatric diseases such as anxiety, which are part of a
larger umbrella of long-term anxiety disorders such as generalized
anxiety disorder (GAD), PTSD, social anxiety and anti-social
behaviors. This review outlines the complex anatomy of the BNST
together with its diversity and interconnectivity. It then discusses
the role of the BNST in stress-related psychiatric disease. It
concludes with a discussion on the importance of gender disparities
in these psychiatric disorders and the possible role of the BNST.
These topics aim to help the reader gauge the profound promise of
the BNST as a potential target for the treatment of stress-related
psychiatric diseases.
BNST’s vs amygdala’s role in fear and anxiety
In rodents, the BNST is a center for integration of information with
negative valence or anxiety-like states due to the vastly studied
role of corticotrophin-releasing factor (CRF) containing projections
to the amygdala, which releases CRF from the central amygdala
(CeA) that go on to activate the hypothalamic–pituitary–adrenal
(HPA) axis.2,24 Previous research has established the BNST’s role in
sustained fear (which we will term here 'anxiety') as distinct from
the amygdala’s role in phasic fear, (which we will refer to as 'fear').2
Studies have suggested that the amygdala is responsible for
mediating specific cue-based fear responses, and thus controls the
assessment of immediate or phasic fear. The basolateral amygdala
receives sensory input25 about a threat and passes the information
on to the CeA, which has the capacity to modify the HPA axis.26
Fear conditioning studies have indicated that the BNST’s action is
related to the ability to differentiate between safe and non-safe
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contexts,27 which suggests BNST activity depends on contextual
cue reminders that do not predict immediate threat, but rather
cause a sustained state of apprehension.2 Blanchard & Blanchard’s28
earlier work on defensive and anxiety-like behaviors in rodents has
suggested that fear and anxiety can be divided into an immediate
threat, for example, the presence of a predator, and pre- or
post-encounter threats, for example, the apprehension of
encountering a predator again. The BNST is hypothesized
to mediate these longer-term responses to anxiety, where
a challenge or recovery from a challenge to homeostasis occurs.
In contrast, the CeA is thought to mediate shorter duration phasic
fear responses, which occur in response to a current challenge to
homeostasis.2
The amygdala’s response to threat is highly individual and often
critical to the perception of the threat.29,30 The role of the
amygdala cannot be ignored as it can predispose an individual to
an exaggerated stress response when a threat is encountered.
Admon et al.29 showed that new army recruits (that is, yet to
engage in combat) with more responsive amygdalae were more
likely to have greater stress symptoms after a traumatic event.
Whalen et al.30 demonstrated hyper-responsiveness to faces in the
amygdala of PTSD patients.
In contrast, studies in both male and female patients with
phobias, which cause anxiety states, show functional magnetic
resonance imaging (fMRI) activation of the BNST, anterior
cingulate cortex and insula in anticipation to visual stimuli of
phobia-inducing objects (such as spiders), with no activation in
the amygdala.31 Another study in which a real Tarantula spider
was used during brain imaging in healthy male and female
participants, found that the closer the Tarantula was placed to the
foot of the participant, the greater the activity in the BNST, but
also in the amygdala.32 This suggests diffuse states of threat
apprehension are represented differently to the presence of an
actual threat; while only the BNST is active during imagery of a
future threat, both the BNST and amygdala are activated when
faced with an actual threat.
Other models used in human fMRI studies include models of
unpredictable shock vs predictable shock or loss of control, in
which a threat is anticipated. In both female and male adults,
greater BNST activation was found during periods when
unpredictable shock was expected, in contrast to the amygdala,
which was activated in predictable shock context.33 Using a
different model of unpredictability, Somerville et al.34 created an
experiment in which participants were asked to manipulate
parameters on the monitor. When the line on the screen fell below
threshold the participant was shocked. However, in reality the
participants’ keyboard was not connected to the computer.
Authors found that in both sexes BNST activation was greater
when the threat of impeding shock was looming and loss of
control was gauged.34
Games involving high monetary uncertainty increased
activation in the BNST seen with fMRI BOLD in GAD patients
compared with controls.35 In another study, in which the BNST
was activated, there was a significant correlation with anxiety
levels, while only weak amygdala activation was observed.36
The BNST therefore mediates the anticipatory phase of a threat
as well as the general apprehension due to threat and loss of
control to prevent the threat. However, when an actual physical
threat is present both the BNST and amygdala will be activated.
BNST’s vs amygdala’s role in social behavior
Social decisions requiring the initiation of positive or negative
interactions are generated via interactions between the highly
interconnected nodes in the social network such as the
vomeronasal cavity, the MeA, VTA, several nuclei of the
hypothalamus such as the preoptic area, anterior hypothalamus
and the ventromedial hypothalamus.37,38 Convergence of sensory
input and limbic networks outputs about mood, homeostasis and
reward occur in the BNST, as previously mentioned.38 The BNST,
and in particular, its medial and posterior regions, are directly
linked to the social behavioral network that regulates behaviors
including aggression and defensive behaviors, social communica-
tion, mating and parental care.3,4,6,38,39 In particular, social
information in rodents is transferred to the BNST via inputs from
the vomeronasal organ to the olfactory bulb and project bilaterally
to either the lateral septum or MeA.38,40 Partner preference and
copulation behaviors are also heavily mediated by the BNST with
bilateral connections to the MeA.37,38,41 After the sensory
information to the BNST is processed; the BNST and other nodes
in the network can initiate an appropriate social behavioral
response.
The MeA mediates social memory and social recognition via its
direct connections with the olfactory bulb. Oxytocin in the MeA was
found to be crucial and sufficient for social recognition.3,42
Manipulations of the MeA, such as lesion or stimulation can in
males, impair copulation and reduce contact with familiar
females,37,43 and in females mediate an opposite-sex odor
preference.44,45 Lesions of the vomeronasal organ do not change
c-Fos expression in the BNST,46 suggesting a dissociation between
the two areas. The BNST is involved in precopulatory motivation
behaviors for finding a mating partner in both males and females
voles,37,43 and opposite-sex odor preference in female golden
hamsters.44,45 In males, this is demonstrated by increases in BNST
androgen receptor expression and testosterone rises in response to
receptive females precopulation, as in other nodes of the social
network. However, in contrast to other nodes, there is no drop in
postcopulation androgens and testosterone levels in the BNST as
occurs in MeA after ejaculation.47 In addition, males lose attraction
to female odors following posterior medial BNST lesions, though
the ability to discriminate between social and non-social odors
remain.48 In females, evidence shows that oxytocin receptors in the
BNST are responsible for vaginal marking to solicit males and
lesions abolish preference for solicitation to males over females.48,49
Finally, in songbirds, BNST neurons can show differential
activation to positive and negative social attraction, affiliation or
competition, respectively, based on accessibility to a mate.50
Vasopressin (AVP) immunoreactivity in the BNST is detected when
a potential mate or existing partner is present.50 Higher levels of
AVP immunoreactivity are seen in social species in which partners
are present in flocking vs anti-social species.50 Unlike the well-
investigated role of the BNST in fear and anxiety, the role of the
social BNST is still emerging as distinct from the amygdala. From
the above studies, we can conclude that while the two areas are
highly interconnected, specific lesion studies have demonstrated
that the role of the BNST involves positive valence, preference and
motivation for sexual behaviors that are distinct from mere
recognition of opposite-sex conspecifics in context.
The integrated role of the BNST: 'valence surveillance'
To properly understand the seemingly diverse properties of the
BNST such as sustained fear and social behaviors, the two roles
attributed to the BNST must be reconciled. The BNST has long
been understood to assess contextual threat,27 fear-potentiation51
or unconditioned fear.52 However, these studies only used single
male mice in a non-social fear conditioning system or startle
apparatuses, which enables monitoring safety from a physical
threat from the environment. However, negative social encounters
can also be considered a physical threat and predator stress or
apprehension toward a negative encounter can cause anxiety,28 a
socially based type. Therefore, the BNST collectively may assess
sensory information from the physical/social environment. Sen-
sory information may include conspecific or interspecies indivi-
duals in that context. In addition internally, the BNST may assess
the current mood and arousal, which would determine the
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physical readiness. Together, this accumulation of information will
be used to make decisions about the proper response to changes
in the physical environment or in the social setting. For example,
the return to an inhabitable shelter or the scent of an aggressive
conspecific both represent a unspecified threat that can initiate
the stress response in the absence of an immediate threat.
Alternatively, certain contexts that do not require fight or flight,
might be rewarding due to the presence of food or possible
mating and BNST-mediated systems will initiate interaction.
Therefore, opposing BNST circuits maintained by distinct,
opposing sub-nuclei and neurotransmitter systems, as suggested
in the study by Daniel et al.,53 may regulate these shifts from
homeostasis to stress and vice versa53 depending on the
conditions and BNST activation patterns.
We therefore propose a unified role for the BNST in the
surveillance and assignment of valence to the information
collected. The integrated information can then be used to shift
from homeostasis to fight or flight with the help of the BNST’s
control of the activation or attenuation of the HPA axis.54 In
addition, autonomic control of food, fluid intake and micturition13,16
are adjusted for the proper response, if necessary. Alternatively,
connections with the reward and pain systems may monitor
positive valence and adjust information on mood via projections
with serotonergic centers.12 The term 'valence surveillance' unifies
both the apprehension and social roles of the BNST. In fact, its role
in every situation, whether social or not, is to assess the valence
either negatively or positively and then, together with the mood,
energy and motivation status input coming from relevant brain
areas, act appropriately. While extensive anatomical research has
been conducted on the BNST, the functionality of each subregion
and its connectivity has yet to be dissected systematically with
respect to the coordination of these behaviors.
BNST: anatomy in rodents
To better understand how the BNST can integrate information from
multiple brain areas to perform 'valence surveillance,' the diversity
of the sub-nuclei, projections and subpopulations of this medial
forebrain area must be examined. This review will weave through
the majority of sub-nuclei and provide an outline for firstly their
projections; outputs and inputs and then their subpopulations as
they relate to the overall integrative role of the BNST.
There are several nomenclatures used in the anatomy of the
BNST, of which we explain the anatomy according the series of
papers of Dong & Swanson11,13,16,17,24,55–59 in which anterograde
injections were performed on male rats. The BNST is located
ventral to the septum, above and below the anterior commissure
and anterior to the hypothalamus. It is enclosed on both sides by
the globus pallidus of the basal ganglia. In rodents, the BNST is
comprised of up to 18 subregions60 as anatomical techniques and
nomenclature are updated. The BNST is primarily divided into
anterior and posterior divisions. The anterior division (Figures 1I,
1II, 2I and 2II) includes the following well-accepted subregions,
anterolateral, anteromedial, oval, fusiform, juxtacapsular,
rhomboid, dorsomedial, ventral nucleus, magnocellular,60 in which
each has distinct projections within the BNST and outside of the
Figure 1. Afferent projections of the rodent BNST. Diverse brain areas project to the different sub-nuclei of the BNST and often to several sub-
nuclei (adapted from refs 10–13,23 ). (I) Purple arrows represent incoming projections to the anterolateral (al), anteromedial (am) and ventral
(fu) areas of the BNST at the level of the anterior commissure (ac). (II) Orange arrows represent projections to the anterolateral (al) and
anteromedial (am) BNST areas posterior to the anterior commissure (ac). (III) Green arrows represent projections to the posterior BNST
comprising of three nuclei: the principle (pr), the interfascicular (if ) and the transverse (tr). 3v, third ventricle; ac, anterior commissure; al,
anterolateral BNST; am, anteromedial BNST; Amy, amygdala; BNST, bed nucleus stria terminalis; d, dorsal nucleus; dm, dorsomedial nucleus;
DR, dorsal raphe; FC, frontal cortex; fu, fusiform nucleus; GP, globus pallidus; hypo, hypothalamus; if, interfascicular nucleus; ju, juxtacapsular
nucleus; LC, locus coeruleus; LS, lateral septum; mg, magnocellular nucleus; MPO, medial preoptic area; NTS, nucleus solitary tract; OB,
olfactory bulb; ov, oval nucleus; pr, principle nucleus; PVN, paraventricular nucleus; rh, rhomboid nucleus; st, striatum; tr, transverse nucleus;
VS, ventral subiculum; VTA, ventral tegmental area.
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BNST.56–59,61 The posterior division (Figures 1III and 2III) is comprised
of three well-characterized nuclei: the principal, the interfascicular
and the transverse.13 Figure 3 shows a heatmap summary of the
BNST’s receptors, neurotransmitters, transporters/proteins in 12 of
its sub-nuclei, adapted from the study by Bota et al.60
Anterior division. The oval nucleus integrates information about
mood and negative valence via CRF, GABA, pituitary adenylate
cyclase-activating polypeptide (PACAP), dopamine, encephalin,
while promoting anxiety-like behavior.14 GABAergic projections
from the oval nucleus reach the CeA, VTA and the lateral
hypothalamus.24 CeA GABAergic neurons project to the lateral
areas both dorsal and ventral to the anterior commissure, with a
subset co-expressing CRF,62 which respond differentially to the
CRF-expressing neurons of the fusiform nucleus.53 CRF mRNA
levels in the dorsal BNST, now understood to refer to the oval
nucleus, are increased after chronic stress and foot shock unlike
the ventral BNST.53 PACAP and its receptor PAC1 are found in the
oval nucleus and interact with CRF-positive neurons.63,64
Dopamine receptors in the oval nucleus receive input from the
VTA as well as from the dorsal raphe.65 Optogenetic stimulation of
a population of dopaminergic receptor-labeled neurons in the
oval nucleus were anxiogenic while anterolateral (dorsal area)
stimulation was anxiolytic through receiving differential input
from the basolateral amygdala.62 Enkephalinergic neurons from
the globus pallidus project to the oval nucleus as well as the
anterolateral, rhomboid and juxtacapsular areas.66 The presence of
enkephalin in close proximity to oval CRF neurons may assist in
the shift between negative to positive valence and between
opposing roles of stress induction or return to homeostasis based
on the valence assessment.
The anterolateral BNST, located just ventral of the oval nucleus,
is an area where many of the distinct subpopulations responsible
for shifting BNST roles meet. Convergence of steroid hormone
receptors, oxytocin receptors, regulators such as dopamine- and
cAMP-regulated phosphoprotein (DARP), serotonin receptors,
anxiety-regulation by CRF receptor type 1 (CRFR1) GABAergic
opioid regulation as well as HPA axis modulating connections
occurs in this diverse sub-nuclei. The incoming information
received may imply the integration possibilities about mating,
bonding, neuroendocrine state, with mood and pain pathway
processing.
The anterolateral region sends GABAergic projections to neu-
roendocrine centers of the paraventicular area of the
hypothalamus13 and receives inputs from the ventral subiculum’s
glutamatergic projections,62 a connection involved in negative
feedback of the HPA axis.67 Connections also include reciprocal
dorsal raphe serotonergic inputs12 and outputs.13 Steroid
hormone receptors such as alpha and beta estrogen receptors,68,69
androgen receptors as well as aromatase68,69 and oxytocin receptors
are located in the dorsal areas of the anterolateral BNST.70 Co-
localized populations of DARP32, vasoactive intestinal peptide (VIP),
tyrosine hydroxylase and calcitonin gene-related peptide are also
abundant.71 Interestingly, mu-opioid and kappa-opioid receptors on
GABAergic interneurons in both the oval and anterolateral areas
including rhomboid and juxtacapsular areas synapse on CRFR1
receptors affecting synaptic transmission.72,73 The inputs to the
anterolateral region can therefore assess whether an anxiety-like
Figure 2. Efferent projections of the rodent BNST. The BNST sends diverse and unique projections from different subregions (adapted from
refs 10–13,23). (I) Purple arrows represent outgoing projections from the anterolateral (al), anteromedial (al) and ventral (fu) areas of the BNST
at the level of the anterior commissure (ac). (II) Orange arrows represent projections from anterolateral and medial BNST areas posterior to the
anterior commissure (ac). (III) Green arrows represent projections from the posterior BNST comprising of three nuclei: the principle (pr), the
interfascicular (if ) and the transverse (tr). 3v, third ventricle; ac, anterior commissure; al, anterolateral BNST; am, anteromedial BNST; Amy,
amygdala; BNST, bed nucleus stria terminalis; d, dorsal nucleus; dm, dorsomedial nucleus; DR, dorsal raphe; FC, frontal cortex; fu, fusiform
nucleus; GP, globus pallidus; hypo, hypothalamus; if, interfascicular nucleus; ju, juxtacapsular nucleus; LC, locus coeruleus; LS, lateral septum;
mg, magnocellular nucleus; MPO, medial preoptic area; NTS, nucleus solitary tract; OB, olfactory bulb; ov, oval nucleus; pr, principle nucleus;
PVN, paraventricular nucleus; rh, rhomboid nucleus; st, striatum; tr, transverse nucleus; VS, ventral subiculum; VTA, ventral tegmental area.
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experience awaits or a positive bonding is on the horizon.
Subsequent outputs to the hypothalamus and raphe regions may
influence the behavioral outcome.
While the fusiform, juxtacapsular and rhomboid nuclei have not
been studied in-depth functionally, understanding their parallel
projections to the same neurocircuitry but different nuclei within
the anxiety, reward and pain network may provide useful insights
into the BNST’s integration capabilities.
The fusiform nucleus projects to the CeA, paraventricular
nucleus (PVN), nucleus accumbens, peri-aqueductal gray, which
is involved in pain,74 and reticular nuclei,61 which is involved in
attention. The juxtacapsular nucleus, in contrast projects both to the
CeA, basolateral amygdala, substantia nigra and dorsal raphe.11,61
In other words, their projections are to similar circuitry but to
different nodes of each circuitry. What this may mean in terms of
type of quality of information transferred is very intriguing.
A high number of CRF-positive axons are found in the ventral
lateral regions and CRF mRNA is highly expressed in both the oval
and fusiform nuclei,54 as stated previously as well as mu-opioid,
kappa-opioid receptors and enkephalin immunoreactive cells.66,72,73
The rhomboid nucleus projects to the CeA as well as important
centers all over the brain ranging from mesolimbic reward centers
such as the VTA to the substantia nigra, nucleus accumbens and
globus pallidus.13 In addition, there are also projections to several
areas of the hypothalamus including the PVN, and medial
part of the preoptic hypothalamus, reticular nucleus and
peri-aqueductal gray.13 This sub-nuclei contains GABA, glutamate,
as well as dynorphins,73 part of the opioid system, enkephalin
immunoreactive cells66 and dopamine receptors.60
The ventral BNST has the largest density of noradrenergic fibers
in the brain,62 positioning it as a center of arousal, which
is important in assessing appropriate responses to sensory informa-
tion. The ventral BNST receives inputs from A1 (caudal ventrolateral
medulla) and A2 (nucleus of the solitary tract) cell bodies in the
brainstem, with a small population originating from the locus
coeruleus.62,65 Stimulation of the fusiform’s vast input from the
nucleus of the solitary tract can depress cardiovascular responses.53
Tonic noradrenergic release has also been reported in outputs of the
ventral BNST. Noradrenaline is released in response to synthetic fox
odor (2,3,5-Trimethyl-3-thiazoline), immobilization stress, foot shock
and at the anticipation of a reward that is in the end not
received.53,65,75 Signaling is via presynaptic alpha-2 adrenergic
receptors as well as synergistic facilitation via CRF and alpha-1
adrenergic receptors.62 Overall the ventral BNST is an important
center for arousal, which may play an important role in assessing
readiness to respond to either positive or negative valence.
The anteromedial areas of the BNST are part of a unique circuitry
of stress-regulated autonomic control that receives inputs from
medial preoptic area (MPOA),16 and other hypothalamic areas,16 as




























































































Figure 3. Heatmap representing subpopulations of receptors,
neurotransmitters and transporters in all subregions of the BNST.
Adapted from the study by Bota et al.60 with the following genes
added: DARPP32,71 CGRP,71 VIP,71 PAC1,63 PACAP,63,64 CRFR1,81
CRFR2,67,81 PR,68,69 A1-Adr,62,96 A2-Adr,62,65 B1-Adr,53,62,65
B2-Adr.62,65 The original data were extracted from the study by
Bota et al.60 which categorized the expression levels from 0 to 9,
with 12 having no data. In our version, we binned all the genes
previously published and newly added from 0 to 3, 4 to 6, 6 to 9 and
no data into 4 ranks of strong, moderate, weak expression and no
data to combine all the data into the qualitative expression
heatmap. A1-Adr, adrenergic receptor alpha-1; A2-1 GABA A,
GABRA2, GABA a2 receptor; A2-Adr, adrenergic receptor alpha-2;
A3-1 GABA A, GABA3, GABA a3 receptor, B1-1 GABA A, GABA beta 1
receptor; AII, angiotensin I; AR, androgen receptor; AVP, vasopres-
sion; B1-Adr, adrenergic receptor beta 1; B2-Adr, adrenergic receptor
beta 2; B3-1 GABA A, GABA beta 3 receptor; CaB, calbindin; CB-1R,
cannabinoid receptor 1; CCK, cholecystokinin; CGRP, calcitonin gene-
related peptide; ChAT, choline acetyltransferase; CR, calretinin;
CRFR1, cortiotrophin releasing factor receptor type 1; CRFR2,
corticotrophin-releasing factor, receptor type 2; D1, Drd1A, dopa-
mine receptor type 1A; D2, Drd2A, dopamine receptor type 2A;
DARPP32, dopamine- and cAMP-regulated phosphoprotein; DOR,
delta opioid receptor; DYN, dynorphin; ENK, enkelphalin; ER,
estrogen receptors; G1-1 GABA A, GABA, gamma 1 receptor;
GAD65, glutamate decarboxylase 65; GAD67, glutamate decarbox-
ylase 67; GAL, galanin; GluR7, GRIK3, kainate receptor; GlurR5, GRIK1
kainate receptor; Htr1A, 5Ht1A, serotonin receptor type 1; KA2, GRIK
5, kainate receptor; KOR, kappa-opioid receptor; mGluR2, metabo-
tropic glutamate receptor 2; mGluR7A, metabotropic glutamate
receptor 7A; mGluR7B, metabotropic glutamate receptor 7B; MOR,
mu-opioid receptor; nChR, nicotinic acetylcholine receptor; NK3,
tachykinin receptor 3; NKB, neurokinin B; NPY, neuropeptide Y; NPY1,
neuropeptide Y receptor Y1; NPY2, neuropeptide Y receptor Y2;
NPY4, neuropeptide Y receptor Y4; NPY5, neuropeptide Y receptor
Y5; NT, neurotensin; Oxt-1A, oxytocin receptor 1A; Oxt-1B, oxytocin
receptor 1B; PAC1, Adcyap1r1, pituitary adenylate cyclase-activating
polypeptide type 1; PACAP, pituitary adenylate cyclase-activating
polypeptide; PR, progesterone receptor; SOM, somatostatin; SP,
substance P; VGLUT1, vesicular glutamate transporter 1; VGLUT2,
vesicular glutamate transporter 2; VGLUT3, vesicular glutamate
transporter 3; VIP, vasoactive intestinal peptide.
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either activate or attenuate the HPA axis peripheral changes based
on the olfactory information received.
The anteromedial group projections (see Figure 2I) are distinct
from that of the anterolateral, which has more sensory and motor
related projections to the vagus nerve controlling digestive
homeostasis,16 while the anteromedial projects to Barrington’s
nucleus, which is involved in drinking and fluid homeostasis.16
This region has the highest density of direct projections to the
PVN of any brain region and also projects directly to the CeA.16
From the PVN, projections descend to the brainstem to regulate
pelvic functions via the Barrington’s nucleus.16 Interaction with the
PVN and digestive homeostasis is most likely critical for HPA axis
response and fight or flight implementation, in which digestive
activity is ebbed.77 This nuclei is also enlarged after antenatal
glucocorticoid exposure.78
The dorsomedial BNST may be central for the integration of
social information, and if necessary activation of the HPA axis to
initiate fight or flight behaviors and adjustment of mood and
reward circuitry. This region is located ventral to the anterior
commissure and medial to the fusiform nucleus. This subregion
has the most extensive direct projections to the hypothalamus.55
It additionally projects to AVP neurons in the supraoptic region, to
oxytocin neuronal cell bodies in the magnocellular region of the
PVN and to the median preoptic nucleus.55 It also projects to
parvocellular PVN neurons that produce thyrotropin-releasing
hormone, CRF, somatostatin and gonadotropin-releasing
hormone.55 Projections to the PVN are mostly GABAergic and
innervate the parvocellular and magnocellular neurons of the PVN.
Progesterone receptors are found in the ventral medial BNST.68,69
The dorsomedial nucleus (see Figure 2II) receives input from the
basomedial amygdala, MeA and the CeA, as well as the ventral
subiculum of the hippocampus, the insula and infralimbic
prefrontal regions.55 Inputs to the dorsomedial nucleus also
include dopaminergic projections from the VTA, serotonergic
neurons from the raphe nuclei and noradrenergic neurons from
the locus coeruleus and nucleus of the solitary tract.55 Inputs from
the ventral subiculum, the output of the hippocampus, are
primarily glutamatergic.62 Lesion of this subregion attenuates HPA
axis activity.54
Both the dorsomedial and magnocellular neurons also project
to preautonomic neurons in PVN, which project to the spinal cord
and Barrington’s nucleus which innervates the bladder and the
colon.55,56 Therefore, these nuclei might play a role in integration
of information necessary for neuroendocrine and autonomic
control of voluntary drinking behavior, fluid balance, sodium
regulation, especially micturition, defection and erection.56 Many
of these behaviors are affected as part of the flight or fight
response, but prolonged stress or chronic CRF may also
dysregulate autonomic systems.79
Posterior BNST. The posterior division of the BNST is comprised of
three nuclei: the principal, the interfascicular and the transverse
(see Figure 1III and Figure 2III).17 The posterior BNST receives
GABAergic input from the dorsal lateral septum, medial CeA and
Figure 4. Anatomy and subdivisions (red text) of the human anterior BNST (left panel) and posterior BNST (right panel). The orange dots
depict the network of brain areas with either anatomical connection or which have been implicated in its functional connectivity. Image
adapted from Atlas of the Human Brain (http://www.thehumanbrain.info). ac, anterior commissure; Acc, nucleus accumbens; BLA, basal lateral
nucleus of the amygdala; BM, basal medial nucleus of the amygdala; BNST, bed nucleus of the stria terminalis; BNSTc, bed nucleus of the stria
terminalis central subdivision; BNSTL, bed nucleus of the stria terminalis lateral subdivision; BNSTm, bed nucleus of the stria terminalis medial
subdivision; BNSTv, bed nucleus of the stria terminalis ventral subdivision; Cd, caudate; DB, diagonal band; Ent, entorhinal cortex; FPu,
putaminal fundus region; GPe, globus pallidus external; Ic, internal capsule; LA, lateral nucleus of the anygdala; LH, lateral hypothalamus; LS,
lateral septum; mPFC, medial prefrontal cortex; MPO, medial preoptic nucleus; oc, optic chiasm; PirF, piriform cortex; Pu, putamen; PVN,
paraverntricular nucleus; Sch, suprachiasmatic nucleus; VP, ventral pallidum; vPFC, ventral prefrontal cortex.
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MeA posterior dorsal and MeA posterior ventral regions.37,76
Glutamatergic input to the posterior BNST comes from the
paraventricular thalamus, basomedial amygdala, cortical amygdala,
CA1 of the hippocampus and ventral subiculum.80 This division is
also rich in CRF type 2 receptors (CRFR2).67,81 The posterior region
of the BNST is sexually dimorphic with distinct alpha and beta
estrogen receptors as well as androgen populations.68,69 AVP
receptors are located in the posteriolateral region70 and often
interact with androgen receptors.
Connections of the principal nucleus may play a role in
inhibition of other medial BNST areas involved in HPA axis
activation based on assigned valence information obtained from
the social behavioral network connections. The principal nucleus
innervates the septum17 and many hypothalamic areas involved in
reproduction and defensive behaviors in rodents.17,82 These areas
include the MPOA, pre-mammillary bodies, ventromedial hypotha-
lamus and PVN.17 The principal nucleus has high expression of
GAD65 (a GABA-synthesizing enzyme) mRNA.83 The posterior part
also has many intra-BNST projections mainly to medial areas such
as the magnocellular nuclei and dorsomedial BNST.17 It has also
been shown to attenuate the HPA axis.54,67
The transverse and intrafasicular nuclei send projections to
mesolimbic brain regions such as the VTA and substantia nigra17
and receive projections from the anterior olfactory bulb and MeA,
suggesting a role in social recogntion.44 In addition, fibers from
the MeA pass through the BNST via the transverse and
intrafascicular nucleus to innervate the septum.17 The transverse
nucleus alone innervates the PVN, in particular the parvocellular
stress-regulating neurons, which are GABAergic.17
To conclude, the posterior region’s connectivity suggests its
involvement in reproduction and social defensive behaviors via
modulation of the PVN. Additional interplay with the anteromedial
BNST nuclei,17 via the principal nucleus, enables posterior division
to maintain homeostasis in response to the stress of survival and
HPA responsiveness. Based on the above evidence, interactions
with the VTA may provide integration on motivation to engage in
social behaviors after identification of the social benefits of the
encounter by other social network circuitry. Activation of the HPA
axis could be dependent on the outcome of the decision-making
process of valence attachment to the encounter.
BNST: anatomy in humans
While in rodents the BNST’s anatomy and connectivity have been
well-characterized, functional connectivity in humans has been
addressed only recently. Using post-mortem tissue, the anatomy
of human BNST has been mapped immunohistochemically.84
However, recent technological advancement such as improve-
ment in magnetic field strength, allow imaging in higher spatial
resolution of 7 T,85 which has helped visualize this small area.
Emerging fMRI studies have described significant activation in the
BNST accompanying anticipatory anxiety.31,34
The human BNST can be divided into lateral, medial, central84
and ventral subdivisons (see Figure 4). The lateral, medial and
central regions are grouped together anteriorly at the level of the
anterior commissure (see Figure 4, anterior panel) becoming
smaller and joining the ventral region more posteriorly (see
Figure 4, posterior panel). Like in rodents, it is a sexually dimorphic
structure, with human male brains having a BNST 2.5 times greater
in volume than females.18 In a recent report three distinct,
ipsilateral fiber pathways of the human BNST were described: the
posterior bundle, the ventral bundle and the anterior bundle.86
The posterior bundle connects the BNST via the stria terminalis to
the lateral amygdala. The ventral bundle connects the BNST
through the ansa peduncularis to the MeA and hypothalamus.
Both of these pathways match those found in animal models.87
However, the anterior pathway has not been reported previously.
The anterior bundle runs through the head of the caudate body
and nucleus accumbens to the mPFC and the orbitofrontal
cortex.86 The authors also reported that BNST connections to the
brainstem were subject to substantial inter-individual variability.
FMRI scans of rhesus monkeys and young humans show
functional resting state connectivity between the CeA and BNST
signal88 and a significant likelihood of structural connectivity to
the CeA as well as to the temporal pole, a paralimbic area.89 The
human temporal pole is reported to be involved in the coupling of
high level sensory processing and emotions. For example, lesions
can cause intolerance of auditory stimuli coupled with increases in
contextual fear, or loss of link between faces and names, which
causes social deficits.90 In addition, the BNST was shown to be
functionally connected to the thalamus, insula and mPFC in an
emotional task requiring the subject to distinguish between safe
and non-safe contexts.91 FMRI studies also show functional
connectivity of the BNST with the ventromedial prefrontal cortex
(vmPFC), with vmPFC-lesion patients showing decreased blood
flow in the right BNST.92 The vmPFC has been previously
associated with arousal and emotion evoking stimuli.93 An
additional, functional connection was established with the
paracingulate gyrus, also part of the prefrontal cortex and thought
to be involved in anxiety and addiction.85 With enhanced imaging
capabilities, functional connectivity studies and fMRI studies
mapping higher cognitive functions will hopefully emerge to
help us understand the neural circuitry of psychiatric BNST-related
disorders.
Psychiatric disorders and their treatments: involvement of the
BNST
Anxiety. An anxiety disorder is diagnosed when a patient presents
with 'excessive worry' or negative valence about a variety of
situations or contexts and difficulty in controlling these thoughts,
Figure 5. Summary representing the behaviors that the BNST
regulates and implicated pathology in event of dysfunction of
connectivity or neurotransmitter populations. BNST, bed nucleus of
the stria terminalis.
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which in turn may cause difficulty sleeping and concentrating or
irritability.7 These symptoms affect the daily functioning of an
individual over a sustained period of time.9 Anxiety disorders are
treated using anti-depressants such as selective serotonin reuptake
inhibitors (SSRIs), selective norepinephrine reuptake inhibitor
(SNRIs) or benzodiazepines, which facilitate GABA transmission
(less commonly used due to dependence problems).2,7,22
Currently available anti-depressants, which increase serotonin
levels, either activate the BNST chronically or activate behaviors
that are BNST-mediated. In rodents, as consistent with the BNST’s
proposed role in 'valence surveillance,' projections to the
anterolateral BNST have the greatest serotonergic innervation in
the brain from the caudal dorsal raphe and can shift mood based
on the specific serotonergic receptor types activated. Anxiogenic
vs anxiolytic behaviors depend on the specific serotonergic
receptor type activation23 and the BNST contains many serotonin
receptors which are the major targets of anxiety disorder
treatments: Htr1A, Htr2A, Htr2C and Htr7.
12,94 Htr1A autoreceptors
mediate the inhibitory response of the BNST to serotonin. In
contrast, Htr2A and Htr2C mediate anxiogenic behavior via
depolarization in response to serotonin.12,94 Co-localized interac-
tions between this serotonergic population and CRF may also play
a role in the antidepressant effects described above12 in particular
in the oval nucleus.22 The BNST also contains alpha and beta
adrenergic receptors and subtypes, 53,62 possibly involved in
arousal state and may be the reason for the efficacy in some
patients of SNRIs.
GABAeric transmission, the target of benzodiazepines used to
treat anxiety, includes abundant projections from the anterome-
dial BNST to the PVN.62,95 Changes in GABA receptors in the
dorsomedial and principal nuclei under chronic stress conditions
have been demonstrated.96 It is also these two areas that regulate
the activation or attenuation of the HPA axis, respectfully54,67,97
therefore possibly shifting anxiogenic states to anxiolytic states. In
addition, the BNST–VTA GABAergic pathway reduces anxiety,98
however, activation of this connection while effective, may also
cause dependence and explain the reduction in popularity of
benzodiazepine treatment in favor of SSRIs.
While many rodent and human studies look at the effect of
both acute and chronic SSRI treatments on fear and anxiety, in
reality, treatment involves long-term administration.22 In male rats,
acute systemic fluoxetine, a type of SSRI, treatment increases Arc,
an intermediate early gene, expression in the dorsal lateral areas
of BNST and in the CeA.23 Local infusions of acute fluoxetine
initially exacerbate anxiety-like behavior and conditioned fear
memories in the BNST but not in the CeA.23 Chronic fluoxetine,
reduces stress-induced BNST c-Fos99 and inhibits sustained fear,
but not phasic fear.100
Sustained fear in general is susceptible to clinical intervention
with SSRIs, making the study of anxiety disorders, their
pharmacology and the BNST more relevant for clinical success.2
Acute tryptophan depletion meant to model low serotonin levels,
in human subjects increases eyeblink startle, a BNST-mediated
paradigm, to context but not cued stimuli.101 The above data
demonstrate not only the BNST’s role in anxiety, but its role in the
responsiveness to SSRI treatments, which require shifts from
anxiogenic to anyxiolytic after chronic administration.
Chronic SSRI treatment was effective in both rodents and
humans in models of sustained fear such as light- and dark-
enhanced startle as well.2 Startle studies of sustained fear in both
male rodents and male humans show that acute administration of
citalopram, an SSRI, increases fear and anxiety in response to
shocks, while chronic administration reduces contextual anxiety
but not cued fear.2 Human studies show reduction in startle with
chronic benzodiazepines administration while rodent studies
demonstrated an anxiolytic effect.2,100
With an 18% prevalence rate of people who experience anxiety
for a 12-month period,102 research on the BNST, known to mediate
extended fear states in both humans and male rodents should be
a priority for future pharmaceutical treatments. While anxiety has
been the most intensively researched BNST-based psychiatric
disorder, research is yet to encapsulate the full complexity of the
shifts between anxiogenic vs anxiolytic states in BNST nuclei-
specific neurotransmitter systems and connections.
Post-traumatic stress disorder. PTSD is a severely debilitating
psychiatric condition characterized by persistent symptoms of
intrusive re-experience, avoidance and hyperarousal months to
years following exposure to a traumatic event.8,103 PTSD patients
show sustained fear behaviors attributed to the BNST, which may
imply impaired 'valence surveillance.' Neurobiological changes in
PTSD patients reflect shifts in integration of arousal, HPA axis
activation and mood state that may impair realistic decisions about
threat. Levels of cortisol, a heavily debated biomarker in PTSD,104
are also mediated by output from the BNST.54 Hyperarousal is
mediated by noradrenergic projections to the BNST62 and negative
valence by sertonergic inputs abundant in the BNST.12 The high
comorbidity of drug abuse with PTSD103 also implies shifts in mood
and appetite for increasing positive mood states.
PTSD patients, in particular, exhibit measurable sustained fear as
demonstrated by startle and loss of control paradigms. Similar to
patients with GAD, the most effective clinical treatments today are
SSRIs and SNRIs. Grillion et al.105 show increased sustained fear in
PTSD patients, but not in GAD patients, suggesting involvement of
the BNST. Furthermore, two studies which measured single
nucleotide polymorphisms (SNPs) in blood samples of PTSD
patients, showed SNPs of genes also expressed by BNST
neurons.106,107 Interestingly, in both studies the effects were specific
to female PTSD patients. Female PTSD patients show a significant
association of SNPs for CRFR2, and PAC1 (ADCYAP1R1) with risk to
develop PTSD and with severity of PTSD symptoms.106,107 White,
non-hispanic females cohabitating with traumatized combat
veterans with PTSD were found to have significantly reduced
lifetime risk of developing PTSD, associated with two CRFR2 SNPs.106
One SNP was also associated with severity of PTSD.106
In animal models, a possible mechanism for sustained fear is, in
fact, the CRFR2, which mediates coping with challenges to
homeostasis. The role of coping is actually an important
component of the BNST’s proposed role of 'valence surveillance'
in that coping requires physiological shifts based on new sensory
information collected. While CRF/CRFR1 systems are involved in
initiation of the stress response, CRFR2 involves turning off stressful
responses when the stressor is no longer present.108 Knockdown of
CRFR2, specifically in the BNST of male mice was also shown to
cause changes in anxiety-like behaviors 24 or 48 h after restraint,
but not right after (Lebow et al., unpublished data). Furthermore,
CRFR2KD in the BNST was demonstrated to be involved in
increased arousal and vigilance67 and robust changes in CRFR2
mRNA were exhibited in the BNST of PTSD-like mice that
underwent unpredictable shock.67 The effects of CRFR2 are also
proven to be sex-specific, with only CRFR2 female knockout mice
showing increased anxiety-like and depressive-like behaviors.109 As
such, BNST CRFR2 could represent a future target for human
psychopharmacology in which initiation of downstream coping
genes could possibly reduce PTSD symptoms of sustained fear and
shift negative valence to positive valence. Furthermore, the BNST’s
CRFR2s may have sex-specific effects in psychiatric disorders.
PACAP is another rodent and human target that may hold
promise for the future treatment of PTSD, in a sex-specific manner,
given it is heavily expressed in the BNST. PACAP is localized in the
oval nucleus of the rodents BNST, where it is known to innervate
CRF-expressing neurons12 and where it has been shown to cause
increased anxiety states.63 BNST PACAP also stimulates activation
of the HPA axis.110 Continuous blockade of PAC1 during chronic
stress reverses this effect.110 A single human SNP in the PAC1
(ADCYAP1R1) gene, which is located in an estrogen responsive
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element, was recently found to be a predictor for PTSD and
to be associated with severity of PTSD symptoms in a highly
traumatized cohort of African-American women. Furthermore,
methylation of this gene in patient blood was found to correlate
with total PTSD symptom load only in women.107
Human psychiatric diseases such as anxiety and PTSD are also
accompanied by changes in cortisol levels. Changes in cortisol are
also a function of the proposed BNST’s role of 'valence
surveillance,' in that information about the environment must
be processed to activate the stress response or to turn it off. PTSD
patients show reduced cortisol and this is mirrored in PTSD-like
animal models which show reduced corticosterone levels.67,111–115
Accordingly lesions of the posterior medial BNST in male rats
cause increases in corticosterone levels 30 min after restraint
stress, while lesions of the anterior ventral BNST attenuate
corticosterone levels immediately after restraint stress.83,97 The
anterior BNST serves as a relay station between the mPFC and the
PVN that mediate HPA responses to stress15 to activate the HPA
axis and causes corticosterone release, while the posterior BNST
inhibits the HPA axis and attenuates corticosterone release.54,83
SSRIs are considered the most accepted treatment for PTSD
symptoms in patients, and other treatments all target serotonin,
dopamine, norepinephrine and GABAergic systems though not
always most effectively,116 and self-administration of alcohol is
also rampant.103 While the most effective treatment is yet to be
discovered, current treatments are consistent with a mouse model
of PTSD, in which, vast molecular changes take place in
serotoergic, adrenergic and even GABAergic systems in the BNST.
Downregulation of receptor mRNA is seen for adrenergic (Adra2a,
Adrbk1), GABAergic (Gabra2, Gabra3) and serotonergic (Htr1A,
Htr2c, Htr7) receptors.
67 In addition, a metabolite of serotonin,
5-HIAA, showed decreased levels 2 weeks after the unpredictable
shock paradigm and immediately following measurement of the
startle response (personal communication, Christopher Lowry,
University of Colorado), indicating alteration in the BNST serotonin
system in a rodent PTSD model. This might possibly explain the
mechanism of SSRI treatment in PTSD patients who have
increased sustained fear.
PTSD itself is a disorder that is twice as prevalent in females
than males. As reviewed above, the human literature shows
sex-specific changes in PTSD patients in SNPs of genes expressed
in neurons in BNST subpopulations. Overall, this makes the BNST
an excellent target for future research in PTSD and treatment
for PTSD.
Aggression and anti-social behaviors. Aggression is defined as
behavior intended to inflict physical damage on another
individual.4 In humans, aggression can be differentiated into two
types; impulsive aggression in response to anger, often called
reactive aggression, and goal-oriented aggression, which is
referred to as controlled instrumental aggression.4 Reactive
aggression in humans is often the result of PTSD or depression,
which can be due to increased arousal combined with feelings of
helplessness and loss of control. Controlled instrumental
aggression in humans is found in anti-social personality types
who show low arousal and often have emotionally blunted
responses.4 Pharmaceutical drugs used to treat both types of
aggression in humans often involve sedatives or antipsychotics,
which target the serotonin system.117
Psychopathy or other anti-social behaviors characterized by low
empathy and aggression are the result of low arousal and
impaired fear processing.4 Many human studies on psychopathy
focus on impaired fear processing in the amygdala and showed
reduced amygdala activation in fMRI of psychopaths.5 However,
cold calculated long-term decision-making behavior seems to be
outside the realm of the amygdala and rather a frontal cortex
process.
The prefrontal cortex is thought to mediate aggression and
impulse control.4 SSRI treatment in borderline personality disorder
patients increased activity in the prefrontal cortex, ameliorating
the lack of inhibitory control.4 Patients with vmPFC lesions show
blunted arousal to emotional stimuli and reduced BNST activity
was observed.93 Research on anti-social behavior may benefit by
the further study into the frontal cortex and ventral BNST
connections, which could regulate controlled thinking in
anti-social behaviors and influence low arousal states and
aggressive behavior, respectively.
At least in rodents, the BNST’s proposed role as 'valence
surveillance' may be important for indicating the presence of an
aggressor and whether to fight or flight. This is based on the relay
of information from the mPFC to the BNST and from BNST to the
PVN, in which the mPFC inhibits the ventral BNST to activate the
medial parvocellular PVN.15 The decision may also integrate BNST
noradrenergic information to determine or increase readiness. The
noradrenergic population of the BNST could therefore be an
important target for treatment of aggression via its functional
connectivity with the prefrontal cortex.
The ability to engage in aggressive behavior is also necessary in
rodents to obtain resources such as food or mates. These
behaviors are mediated by a vast network of sensory and limbic
information. Olfactory cues transmitted via the social behavior
network mediate aggressive behaviors and lesions in any of these
nodes or in the frontal cortical regions can greatly reduce
aggressive behavior between males.40 Other systems thought to
biologically mediate aggression involve vasopressinergic,4
dopaminergic75,98,118 GABAergic,4,39,118 noradrenergic,4 and
steroid hormones and receptors,4,119 which are all abundant in
the sub-nuclei of the BNST. Aggressive behavior is mediated by
and correlated with vasopressinergic–androgen-dependent
projections from the BNST to the lateral septum.119 There are
positive correlations with estrogen alpha positive neurons in the
BNST, as well as AVP immunoreactivity in the BNST and
aggression.119 The most aggressive rodents also show the highest
oxytocin receptor binding, in medial and posterior sections of the
BNST.120 Aggression is also attributed to the ventromedial
hypothalamus which is highly connected has projections from
the principal nucleus.4,17 As a result, the BNST and its subpopula-
tion of AVP and steroid hormone receptors mediate the initiation
of aggression in rodents after sensory evaluation, while connec-
tions with the frontal cortex mediate changes in homeostasis in
response to the sensory information, further implicating the
BNST’s integration of information for use in implementing
responses to homeostatic challenges.
Social attachment disorders: social anxiety and motivation of bond
formation. The BNST is implicated in the neurobiology of social
attachment behavior in rodents and humans,3,121 which includes
behaviors such as mating between conspecifics and parental
behaviors. Impairments in these BNST-mediated mating behaviors
may also play a role in human social dysfunction such as social
anxiety, autism or inadequate parental care, making a person less
likely to coordinate behaviors to form or maintain the social bonds
necessary for reproductive behaviors. Three stages are critical to
complete the social attachment bonds; inhibition of fear, social
recognition and reward motivation.3 Social anxiety disorder occurs
in 6.8% of the population and is described by a fear of unfamiliar
people who may scrutinize the sufferer in a social situation, which
causes anxiety and social avoidance in the sufferer.122 One of the
consequences of social anxiety disorder on an individual is the
lack of ability to initiate a social bond out of fear and result in
insecurity and increased stress.122 In addition, there is a lack of
sufficient motivation and increases in inhibition of initiation of
these behaviors.122 While the amygdala and frontal cortex may be
crucial for social recognition and inhibition of fear,3 the BNST
through its connections with the VTA3,98 and frontal cortex3 and
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MPOA3 plays an important role in motivation for mating and
anticipation of reward via dopamine and oxytocin circuitry3 or as
hypothesized attaching positive valence to the process based on
'surveillance' information received.
Mating behavior in rodents involves a coordination of complex
precopulatory behaviors such as solicitation behavior and odor
discrimination to facilitate a successful outcome.3,48 Complex
connectivity between the brain circuits containing dopamine,
oxytocin, noradrenaline, GABA and glutamate such as the VTA,
BNST and MPOA may explain these behaviors.
Within the BNST itself, a dissociation exists between dopami-
nergic, GABAergic release in the oval nucleus vs noradrenergic
and glutamatergic release in the ventral BNST based on
presentation of a rewarding cue or anticipation of a rewarding
cue, respectively.65,123 While these systems have mostly been
studied in the context of drug addiction and relapse,124
motivation for mating or anticipation of a mate, may work
through this same circuitry. In fact, dopamine is known to be
involved in pair bonding and pair bonding in social species is
considered to be rewarding.3 Females monogamous voles have
increased BNST oxytocin receptors, which are expressed in both
dorsal and ventral areas of the BNST.60 There is also sex-specific
expression of the dopamine D1 receptor in the lateral BNST in
which males have stronger D1 receptor immunoreactivity.125 It is
hypothesized that oxytocin receptor activation in the BNST and in
the VTA via MPOA release, as well as dopamine release from the
VTA, may mediate motivation to pair bond and monogamy after
the initial rewarding experience is encoded by nucleus accumbens
and VTA.3 In the BNST, increases in glutamate in response to the
rewarding experience also change plasticity and hence motivation
to obtain it.123
There are reciprocal GABAergic connections from the BNST to
the VTA. In addition, VTA to BNST projections are glutamatergic
and have glutamate transporters, suggesting that the BNST
disinhibits VTA dopaminergic neurons, yielding a rewarding
state.126 Optogenetic stimulation of BNST–VTA circuitry provides
evidence of BNST GABAergic connections causing rewarding
states and reduction in anxiety-like states, while BNST glutama-
tergic VTA connections are anxiogenic.98 Therefore, the BNST
mediates the interplay between anxiety, anticipation and reward
that comprises social attachment and the vicious cycle of
substance abuse. In fact several articles have addressed the topic
of the idea that social attachment is a form of addiction.3,124 More
research using BNST-mediated dopamine, oxytocin, CRF, gluta-
mate and GABA in social behavior could elucidate the circuitry of
motivation for a mate and maintaining monogamy.
Inadequate parental attachment and offspring care. Parental
behavior is also considered part of the reward, motivation and
addiction-like circuitry, involving the BNST. Dopamine plays a
critical role in the rewarding aspect, but the BNST oxytocin and
CRFR2 play a role in response to care.3,127
In humans, the brain of new mothers and experienced mothers
show increased activity in fMRI in both the ventral BNST and
amygdala in response to one’s infant crying.121 The amygdala was
additionally activated in other conditions of general emotionally
arousing noise such as cries and laughter of other babies, thus
demonstrating responses to phasic changes in emotional stimuli.
However, in response to visual stimuli of one’s infant, the BNST
showed increased activity in contrast to the amygdala.121 This may
indicate that BNST activation occurs in response to both
emotionally valent auditory and visual stimuli with respect to
one’s infant and not general emotionally arousing information.
In rodents, receptor subpopulations of the posterior BNST, such
as CRFR2 and oxytocin receptors, are also thought to be involved
in maternal care. Hypoactivation in the BNST of CRFR2 is important
for maternal care during lactation.127 Furthermore, oxytocin
receptor levels in the BNST, CeA, MPOA and lateral septum are
correlated with higher frequency of licking and grooming of
pups.3 The human BNST is involved in assessing valence regarding
offspring,121 presumably to act to protect the offspring and
activate systems necessary to do so depending on the valence
levels. In rodents, changes in posterior BNST circuitry and its
projections determine lactation127 and pup care.3
Sex differences and steroid hormones
Any study of the neurobiology of human psychiatric diseases
would be incomplete without mentioning the gross discrepancy
in the prevalence and treatment outcome between the sexes.
Women are two times more likely than men to have a major
depressive episode and more likely to be diagnosed with an
anxiety disorder.20,102 There are also differential success rates in
women vs men in the treatment of depression, with men being
more responsive to imipramine and paroxetine.19 Women are also
twice as likely to develop PTSD after exposure to a trauma128 and
as previously discussed sex-specific SNPs were found for female
PTSD patients.106,107
In addition, the BNST itself, contains subpopulations of
receptors for steroid hormones such as androgen, estrogen (both
alpha and beta subtypes) as well as progesterone,6,47,68,119 which
may interact differently with states of sustained fear and anxiety in
females vs males and influence 'survellience' and attachment of
proper valence to situations.
In rodents, with regard to anxiety-related behaviors, steroid
hormone manipulation affects behavior specifically in
BNST-dependent paradigms. Progesterone reduces CRF-enhanced
startle. Progesterone also activates BNST neurons via oxytocin.129
Intact males have the lowest light-potentiated startle and pregnant
females the highest.69 Testosterone reduces light enhanced startle
in male rats only.
Anatomically, many projections and subpopulation sex differ-
ences can be found in the BNST. The human female BNST has 76%
greater structural connectivity in regions that had significant
connectivity with the BNST.130 In rodents, the AVP pathway
from the BNST to the lateral septum is larger in males131,132
and gonadectomy of hypogonadism reduces BNST AVP
immunoreactivity.133,134 Testosterone exposure causes an increase
in prenatal changes of CRF immunoreactive neurons in the BNST
of ovariectomized rats. This area was more vulnerable than the
MPOA during sexual differentiation.135 The bilateral connections
between the posterior BNST and the MeA may also be involved in
sexual differentiation. While MeA to posterior BNST connections
appear by embryonic day 14, reciprocal projections from the BNST
to the MeA appear by postnatal day 15 during the critical
postnatal period suggesting the necessity of steroid hormones in
completion of these circuits.136 Anatomical and behavioral
differences between the sexes in the BNST or anxiety-related
receptors and behavior might help explain the vast discrepancy
between prevalence rates of human psychiatric diseases between
men and women.
Summary
We propose that the BNST plays the essential role of 'valence
surveillance' by processing salient information taken from the
monitoring of the physical and social contexts. Decisions about
threatening and rewarding situations are accessed while informa-
tion on mood, homeostatic state, arousal, feeding and reproduc-
tion is kept online. Anatomically, the BNST is heterogeneous,
containing many sub-nuclei and an abundant diversity of
neurotransmitters and their receptors. Understanding the
subpopulations and specific connectivity of this diverse area is
critical for understanding its role in pathology and designing
therapeutic interventions. While much research is focused on
understanding human psychiatric diseases by using animal
models to study the amygdala, the literature has somewhat
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overlooked the role of the BNST, which might explain their
complexity. Figure 5 illustrates the proposed roles of the human
BNST and dysfunction associated with impaired BNST function.
Human psychiatric diseases are not only isolated to immediate
altered fear processing but may include vast changes in long-term
anxiety states, arousal, social and reproductive behaviors, in
addition to the often overlooked different manifestations among
the sexes. Therefore, increased understanding of the BNST is sure
to provide profound translational insights for treatments of
human psychiatric diseases.
Future directions. The purpose of this review is to raise awareness
of the plethora of research that is yet to be performed and the
translational relevance of studying the BNST. BNST animal
research has thus far only focused on anatomical projections,
the startle circuitry and on social behaviors. Often in this research,
the BNST is not the main focus of the study, but rather added as
an afterthought and most are performed in non-rodent and
primate species. Advanced models of psychiatric disorders in
rodents unfortunately focus on more well-characterized brain
areas and as such the 'state of the art' genetic toolbox is reserved
for better-understood areas.
For example, anatomical tracing has benefitted by advances in
technology. Combining CRE and flox lines137 and injections of
herpes, an anterograde tracer,138 or rabies, a retrograde tracer,139
would give anatomical information regarding specific subpopula-
tions projections within the known BNST circuitry. Functionally,
CRE lines bred with flox lines can conditionally knockout a specific
gene, from which its function can be accessed via behavioral
changes in its absence. Changes in activation and subsequent
changes in behavior can also be demonstrated using optogenetics
in CRE lines in specific brain nuclei. The teasing out of BNST
circuitry in this way has begun in several recent optogenetic
BNST-focused papers.14,41,73,98,140 There are many permutations
for research using these techniques in that the target projections
from the BNST can be illuminated and tested for changes in
behavior as well as the BNST sub-nuclei that is sending the
projections. At the behavioral level, more BNST-specific paradigms
are needed aside from the startle test, which tests for sustained
fear. Due to the social nature of the BNST, biological markers
such as HPA axis or receptor changes of any of the relevant
subpopulations should be measured after behaviors in a
group setting of same sex or after interactions of both sexes.
Manipulations introducing stressors like shock or reward would be
interesting as they affect the individual responses but in a group
setting would enhance the understanding of the BNST’s proposed
role of 'valence surveillance' in a more ethological setting.
Moreover, the latest advances in epigenetics, including
methylation, acetylation, microRNAs, other small non-coding
RNAs, RNA editing and other bioinformatics pathways from
RNAseq often do not generate BNST-specific data. Arrays of the
genome and micronome of the BNST in general may show unique
patterns after acute or chronic stress or the BNST-specific
paradigms to be generated, as discussed above. Individually
methylated regions based on behavioral experiences may also
provide information about the role of adaptivity in specific BNST
sub-nuclei to environmental exposures. Again and again the
challenge is specific dissection between anterior regions.
The entire field of these potential biomarkers from whole blood
or plasma that correspond to changes in BNST receptor or
neurotransmitter populations has yet to be established in rodents
or humans. mRNA or microRNA levels in the BNST could be
compared with plasma circulating levels to see if BNST levels are
predictive enough for use as biomarkers in psychiatric diseases.
Studies involving animal models of psychiatric disease in both
females and males are also missing in most brain research, but
there is greater rationale for doing so for the BNST. This has left a
large gaping hole in the field of the psychiatric research in animal
models.
While human research is also in its infancy, some strides have
been made in deep brain stimulation specifically for the
BNST.141,142 Other than directly stimulating the BNST, studying
its behavioral-induced fMRI signal as well as the general BNST
functional connectivity during different states and in different
pathologies is of great interest. Post-mortem tissue studies looking
at gene expression changes may bring forward candidate genes
for biomarker diagnostics of psychiatric disorders. Overall, there is
still a vast amount of research needed to understand the full
complexity of the BNST.
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